Viemed Healthcare (VMD) Capital Expenditures Growth (1y) (2019 - 2026)
Viemed Healthcare (VMD) Capital Expenditures Growth (1y) (2019 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.52 Bn | 176.22 Bn | 6.27 Bn | -17.56% |
| 2 | Stryker | 128.83 Bn | 125.95 Bn | 3.81 Bn | 34.96% |
| 3 | Medtronic | 108.61 Bn | 99.39 Bn | 6.41 Bn | 6.32% |
| 4 | Boston Scientific | 68.35 Bn | 66.90 Bn | 3.61 Bn | -5.35% |
| 5 | Edwards Lifesciences | 48.53 Bn | 44.86 Bn | 1.29 Bn | 15.89% |
| 6 | Dexcom | 28.42 Bn | 27.30 Bn | 750.30 Mn | -11.95% |
| 7 | GE HealthCare Technologies | 28.34 Bn | 26.06 Bn | 1.98 Bn | 106.98% |
| 8 | Smith & Nephew | 26.92 Bn | 26.35 Bn | - | - |
| 9 | Koninklijke Philips | 25.49 Bn | 22.36 Bn | 2.07 Bn | -47.73% |
| 10 | Viemed Healthcare | 462.30 Mn | 452.53 Mn | 42.83 Mn | 85.16% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 85.16% |
| Dec 31, 2025 | 80.86% |
| Sep 30, 2025 | -181.14% |
| Jun 30, 2025 | 6,629.63% |
| Mar 31, 2025 | 49.30% |
| Dec 31, 2024 | -48.77% |
| Sep 30, 2024 | 48.49% |
| Jun 30, 2024 | 113.78% |
| Mar 31, 2024 | -48.13% |
| Dec 31, 2023 | -2,903.51% |
| Sep 30, 2023 | 244.13% |
| Jun 30, 2023 | -119.79% |
| Mar 31, 2023 | 4,581.00% |
| Sep 30, 2022 | -1,911.02% |
| Jun 30, 2022 | 705.95% |
| Mar 31, 2022 | -94.44% |
| Sep 30, 2021 | -75.80% |
| Jun 30, 2021 | -219.09% |
| Mar 31, 2021 | -57.42% |
| Dec 31, 2020 | 28.42% |